Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Daiichi Sankyo identifies new pyrrolobenzoxazepine derivatives

Sep. 6, 2011

SkyePharma completes proof-of-concept study of SKP-1052

Sep. 5, 2011

Bayer Schering Pharma discloses novel progesterone receptor antagonists

Sep. 5, 2011

FDA issues update to Reclast drug label regarding risk of kidney failure

Sep. 2, 2011

New phase II study evaluates Dr. Reddy's DRL-17822

Sep. 2, 2011

NattoPharma prepares new vitamin K analogues

Sep. 2, 2011

New 11-beta-HSD1 inhibitor has potent preclinical activity

Sep. 2, 2011

Autologous hematopoietic stem cell therapy successfully treats children with ADA-SCID

Sep. 2, 2011

Mitsubishi Tanabe files for approval of tenegliptin in Japan

Sep. 1, 2011

British company patents novel neuropeptide Y2 receptor ligands

Sep. 1, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...